A Phase I/II Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

RECRUITING

The Second Hospital Of Anhui Medical University, Hefei

RECRUITING

Beijing Cancer Hospital, Beijing

RECRUITING

Beijing Friendship Hospital, Capital Medical University, Beijing

RECRUITING

Chongqing University Cancer Hospital, Chongqing

RECRUITING

The Second Affiliated Hospital Of Chongqing Medical University, Chongqing

NOT_YET_RECRUITING

The First Affiliated Hospital Of Xiamen Univeristy, Xiamen

RECRUITING

Lanzhou University Second Hospital, Lanzhou

RECRUITING

The Third Affiliated Hospital of Southern Medical University, Guangzhou

RECRUITING

The Affiliated Hospital Of Guizhou Medical University, Guiyang

RECRUITING

Henan Cancer Hospital, Zhengzhou

RECRUITING

Zhengzhou Central Hospital, Zhengzhou

RECRUITING

Tongji Hospital, Wuhan

RECRUITING

Hunan Cancer Hospital, Changsha

RECRUITING

The First Affiliated Hospital Of Nanchang University, Nanchang

RECRUITING

Liaoning Cancer Hospital & Institute, Shenyang

RECRUITING

Shandong Provincial Hospital, Jinan

RECRUITING

The Affiliated Hospital Of Qingdao University, Qingdao

RECRUITING

Yantai Yuhuangding Hospital, Yantai

RECRUITING

Shanghai Tenth People's Hospital, Shanghai

RECRUITING

The First Affiliated Hospital Of Xi'An Jiaotong Univeristy, Xi’an

RECRUITING

Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, Chengdu

RECRUITING

West China Hospital Of Sichuan University, Chengdu

RECRUITING

The Affiliated Hospital Of Southwest Medical University, Luzhou

RECRUITING

Mianyang Central Hospital, Mianyang

RECRUITING

The Second Affiliated Hospital Of Kunming Medical University, Kunming

RECRUITING

The Affiliated Hospital Of School Of Medicine Of Ningbo University, Ningbo

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou